Chemed's top three insider shareholders as of March 23, 2026 are Kevin J Mcnamara (President And Ceo, 95.72K shares), Thomas C Hutton (Vice President, 32.48K shares), Joel F Gemunder (Director, 22.77K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Kevin J Mcnamara | President And Ceo | 93,719 | 0 | 13 Mar, 2026 |
| Thomas C Hutton | Vice President | 32,481 | 0 | 17 Feb, 2026 |
| Joel F Gemunder | 22,767 | 0 | 17 May, 2022 | |
| Spencer S Lee | Executive Vice President | 14,912 | 0 | 17 Feb, 2026 |
| Thomas P Rice | 6,028 | 0 | 21 May, 2024 | |
| Michael D Witzeman | Vp Chief Financial Officer | 5,953 | 0 | 17 Feb, 2026 |
| David Patrick Williams | Executive Vice President Cfo | 5,826 | 0 | 15 Nov, 2023 |
| Donald E Saunders | 5,593 | 0 | 17 May, 2022 | |
| Andrea R Lindell | 5,539 | 0 | 29 Dec, 2025 | |
| George J Iii Walsh | 3,523 | 0 | 05 Aug, 2025 | |
| Patrick P Grace | 3,397 | 0 | 10 Sep, 2025 | |
| Brian C Judkins | Vp And Chief Legal Officer | 2,436 | 0 | 17 Feb, 2026 |
| Christopher J Heaney | 2,389 | 0 | 20 May, 2025 | |
| Ron Delyons | 1,666 | 0 | 20 May, 2025 | |
| John Meredith Jr. Mount | 930 | 0 | 20 May, 2025 | |
| Eileen P Mccarthy | 855 | 0 | 20 May, 2025 | |
| Joel L Wherley | Ceo Vitas Healthcare | 852 | 0 | 17 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Mar, 2026 | Kevin J Mcnamara | Capital Stock | D | 2,000 | $403.18 | 93,719 | D | S |
| 13 Feb, 2026 | Thomas C Hutton | Capital Stock | A | 199 | $469.56 | 32,553 | D | M |
| 13 Feb, 2026 | Spencer S Lee | Capital Stock | A | 499 | $469.56 | 15,066 | D | M |
| 13 Feb, 2026 | Joel L Wherley | Capital Stock | A | 273 | $469.56 | 932 | D | M |
| 13 Feb, 2026 | Brian C Judkins | Capital Stock | A | 351 | $469.56 | 2,538 | D | M |
| 13 Feb, 2026 | Michael D Witzeman | Capital Stock | A | 413 | $469.56 | 6,073 | D | M |
| 13 Feb, 2026 | Kevin J Mcnamara | Capital Stock | A | 2,714 | $469.56 | 96,911 | D | M |
| 13 Feb, 2026 | Spencer S Lee | Capital Stock | D | 154 | $469.56 | 14,912 | D | F |
| 13 Feb, 2026 | Kevin J Mcnamara | Capital Stock | D | 1,192 | $469.56 | 95,719 | D | F |
| 13 Feb, 2026 | Brian C Judkins | Capital Stock | D | 102 | $469.56 | 2,436 | D | F |
| 13 Feb, 2026 | Michael D Witzeman | Capital Stock | D | 120 | $469.56 | 5,953 | D | F |
| 13 Feb, 2026 | Joel L Wherley | Capital Stock | D | 80 | $469.56 | 852 | D | F |
| 13 Feb, 2026 | Thomas C Hutton | Capital Stock | D | 72 | $469.56 | 32,481 | D | F |
| 13 Feb, 2026 | Brian C Judkins | Performance Stock Units | D | 283 | $0.00 | 1,681 | D | M |
| 13 Feb, 2026 | Joel L Wherley | Performance Stock Units | D | 220 | $0.00 | 1,290 | D | M |
| 13 Feb, 2026 | Michael D Witzeman | Performance Stock Units | D | 333 | $0.00 | 2,403 | D | M |
| 13 Feb, 2026 | Thomas C Hutton | Performance Stock Units | D | 160 | $0.00 | 774 | D | M |
| 13 Feb, 2026 | Kevin J Mcnamara | Performance Stock Units | D | 2,187 | $0.00 | 10,329 | D | M |
| 13 Feb, 2026 | Spencer S Lee | Performance Stock Units | D | 402 | $0.00 | 1,966 | D | M |
| 13 Feb, 2026 | Kevin J Mcnamara | Performance Stock Units | D | 2,187 | $0.00 | 8,142 | D | M |